Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: INIMMUNE CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-07-31 to 2020-07-31
Current total value of award: $631425
Description: DISCOVERY OF NEW SMALL MOLECULE TLR4 AGONISTS FOR THE TREATMENT OF ALLERGIC RHINITIS'